Latest Diabetic Nephropathy News
Increase in prevalence from 2002-2013, with highest prevalence among those aged 12 to less than 18 years.
The medication significantly decreased potassium levels over 52 weeks in patients with resistant hypertension and diabetic kidney disease.
Higher urinary potassium excretion, not sodium excretion, tied to lower risk of primary end point.
AKI, albuminuria, eGFR considered separately or together can predict adverse outcomes in diabetes.
Significant association found in patients with diabetic nephropathy.
Hyperkalemia occurred in just 1.8% of patients taking finerenone 7.5 to 20 mg daily.
Nonalbuminuric chronic kidney disease was linked to increases in all-cause and cardiovascular mortality, but not albuminuria or end-stage renal disease.
Older patients with more diabetes complications have greater cognitive decline, study finds.
Increased uric acid levels were correlated with decreased HbA1c and increased prevalence of diabetic kidney disease, study finds.
Intense glycemic control was significantly linked to higher risks of cardiovascular and all-cause mortality
Among the increased risks, women with the disease had an 86% higher chance of dying from cardiovascular disease than men.
Researchers in the Netherlands report results from an autopsy study of diabetic nephropathy patients.
Researchers find an independent association in a study of Japanese patients with type 2 diabetes.
Public health efforts needed to ensure adequate access to ophthalmologists.
The drug maintained kidney function in mice with diabetic nephropathy.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)